Recent Quotes (30 days)

You have no recent quotes
chg | %

ALDA Pharmaceuticals Corp  

(Public, CVE:APH)   Watch this stock  
Find more results for APH
0.100
0.000 (0.00%)
Jun 18 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.10 - 0.10
52 week 0.05 - 0.19
Open 0.10
Vol / Avg. 67,100.00/10,354.00
Mkt cap 2.16M
P/E 0.91
Div/yield     -
EPS 0.11
Shares 21.62M
Beta 0.86
Inst. own     -

Key stats and ratios

Q4 (Dec '12) 2012
Net profit margin - -367.77%
Operating margin - -352.40%
EBITD margin - -307.63%
Return on average assets -33.51% -291.89%
Return on average equity -381.94% -
Carbon Disclosure Rating - -

Address

RPO Royal City, PO Box 47264
NEW WESTMINSTER, BC V3L 05A
Canada
+1-604-5218300 (Phone)
+1-604-5218322 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

ALDA Pharmaceuticals Corp. is engaged in the business of developing infection control products for industrial and consumer use and for the treatment of topical infections. The Company�s first product, a surface disinfectant called T36 Disinfex. It is being sold primarily to First Responder organizations, including ambulance, fire fighters and police forces in Canada; dental clinics, and beauty and hair care salons and spas. T36 Disinfex is a mixture of ethanol, o-phenylphenol, benzalkonium chloride and other ingredients (including lemon fragrance and water). All of these component chemicals are bio-degradable. The Company is also engaged in the development of other products, such as T36 Disinfex, T36 Disinfex Disinfectant Cleaner Wipes, T36 Disinfectant Cleaner CONCENTRATE, T36 Hand Sanitizer, T36 Antiseptic Hand Sanitizer Gel, Liquids and Wipes, T36 Medicated Hand Cleanser, T36 Anti-viral Soap, T36 Microbicide Gel, T36 Skin antiseptic and first-aid ointment.

Officers and directors

Terrance G. Owen President, Chief Executive Officer, Director
Age: 66
Jamie Lewin Chief Financial Officer, Director
Eugene Beukman Director
Age: 53
Tom Kennedy Director